SAI projects support clients’ asset and portfolio strategies across immunotherapy, including cell and gene therapies. See some of our oncology team's experience in these areas below.

Contact us to learn more today! http://www.sai-med.com/contact/

#CTOS2022 #ASH2022 #ASH22

Our oncology team has deep, comprehensive experience in emerging technologies from patient selection through biomarker identification, evolution of targeted therapies and immunotherapies and the nuances of global regulatory systems and pathways.
#CTOS22

Dr. Barry has extensive knowledge of the oncology landscape and experience in qualitatively assessing the dynamics of the rapidly evolving space. At SAI, he provides broad strategic support to oncology companies from discovery to LCM.
http://www.sai-med.com/contact/
#CTOS22 #CTOS2022

Our dedicated Oncology Team has extensive experience across a broad range of tumor types, MOAs and technologies, making us the perfect thought partner to help you develop an effective strategy. Schedule a consult: http://www.sai-med.com/contact/

#pharma #lifesciences #CTOS2022 #CTOS22